Carregant...
Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
BACKGROUND: Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunotherapeutic capable of activating innate immune defenses for non-specific protection or early treatment...
Guardat en:
| Publicat a: | BMC Vet Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6743184/ https://ncbi.nlm.nih.gov/pubmed/31519215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-2073-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|